Biosimilar Etanercept Use in Rheumatoid Arthritis: The Rhumadata Registry Experience

被引:0
|
作者
Moura, Cristiano [1 ]
Bernatsky, Sasha [2 ]
Coupal, Louis [3 ]
Bessette, Louis [4 ]
Choquette, Denis [3 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[3] Inst Rhumatol Montreal, Montreal, PQ, Canada
[4] Laval Univ, Quebec City, PQ, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
176
引用
收藏
页码:1107 / 1107
页数:1
相关论文
共 50 条
  • [1] Biosimilar Etanercept Use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: The RHUMADATA® Registry Experience
    Moura, Cristiano S.
    Choquette, Denis
    Coupal, Louis
    Bessette, Louis
    Bernatsky, Sasha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [2] Infliximab Biosimilar use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients: The RHUMADATA Registry Experience
    Moura, Cristiano
    Choquette, Denis
    Coupal, Louis
    Bessette, Louis
    Bernatsky, Sasha
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 819 - 819
  • [3] Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry
    Choquette, Denis
    Sauvageau, Diane
    Bessette, Louis
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S186 - S186
  • [4] USE OF ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE RHUMADATA DATABASE: EXPERIENCE AS FIRST OR SECOND LINE AGENT COMPARED WITH ADALIMUMAB AND ETANERCEPT
    Choquette, D.
    Sauvageau, D.
    Haraoui, B.
    Pelletier, J. -P.
    Raynauld, J. -P.
    Villeneuve, E.
    Coupal, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 449 - 449
  • [5] Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the RHUMADATA® Clinical Database and Registry
    Coupal, Louis
    Haraoui, Boulos
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Choquette, Denis
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1314 - 1314
  • [6] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Laura Chadwick
    Sizheng Zhao
    Eduardo Mysler
    Robert J. Moots
    [J]. Current Rheumatology Reports, 2018, 20
  • [7] Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
    Chadwick, Laura
    Zhao, Sizheng
    Mysler, Eduardo
    Moots, Robert J.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (12)
  • [8] Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry.
    Choquette, Denis
    Bessette, Louis
    Fortin, Isabelle
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S676 - S677
  • [9] COMPARING ABATACEPT TO ADALIMUMAB, ETANERCEPT AND INFLIXIMAB AS FIRST OR SECOND LINE AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS. EXPERIENCE FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Fortin, I.
    Choquette, D.
    Bessette, L.
    Haraoui, B.
    Pelletier, J. -P.
    Raynauld, J. P.
    Remillard, M-A
    Sauvageau, D.
    Villeneuve, E.
    Coupal, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 273 - 274
  • [10] LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis
    Song, Yeong Wook
    Park, Yong-Beom
    Kim, Jinseok
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 1 - 8